Organogenesis Holdings Inc. financial data

Symbol
ORGO on Nasdaq
Location
Canton, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 370% % 21%
Quick Ratio 41% % 23%
Debt-to-equity 47% % -20%
Return On Equity 14% % 4416%
Return On Assets 7.3% % 3797%
Operating Margin 7.9% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128,640,671 shares 1.4%
Common Stock, Shares, Outstanding 126,951,876 shares 0.97%
Entity Public Float $299,400,000 USD 50%
Common Stock, Value, Issued $13,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 126,738,136 shares -3.7%
Weighted Average Number of Shares Outstanding, Diluted 130,248,412 shares -1.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $564,169,000 USD 17%
Cost of Revenue $110,768,000 USD 2%
Research and Development Expense $44,542,000 USD -11%
Operating Income (Loss) $44,694,000 USD 519%
Nonoperating Income (Expense) $2,276,000 USD 306%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $46,970,000 USD 519%
Income Tax Expense (Benefit) $9,938,000 USD 665%
Net Income (Loss) Attributable to Parent $37,032,000 USD 4201%
Earnings Per Share, Basic 0.16 USD/shares 540%
Earnings Per Share, Diluted 0.15 USD/shares 520%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $93,679,000 USD -31%
Accounts Receivable, after Allowance for Credit Loss, Current $217,451,000 USD 98%
Inventory, Net $29,627,000 USD 13%
Assets, Current $362,188,000 USD 27%
Deferred Income Tax Assets, Net $29,962,000 USD -24%
Property, Plant and Equipment, Net $103,711,000 USD 16%
Operating Lease, Right-of-Use Asset $55,749,000 USD 50%
Intangible Assets, Net (Excluding Goodwill) $9,145,000 USD -27%
Goodwill $28,772,000 USD 0%
Other Assets, Noncurrent $9,203,000 USD 84%
Assets $598,730,000 USD 20%
Accounts Payable, Current $31,949,000 USD 11%
Employee-related Liabilities, Current $42,714,000 USD 79%
Accrued Liabilities, Current $49,533,000 USD 26%
Liabilities, Current $100,124,000 USD 29%
Operating Lease, Liability, Noncurrent $22,470,000 USD -11%
Other Liabilities, Noncurrent $1,193,000 USD 33%
Liabilities $164,812,000 USD 46%
Retained Earnings (Accumulated Deficit) $3,078,000 USD 92%
Stockholders' Equity Attributable to Parent $300,129,000 USD 14%
Liabilities and Equity $598,730,000 USD 20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $19,935,000 USD -96%
Net Cash Provided by (Used in) Financing Activities $2,056,000 USD 21%
Net Cash Provided by (Used in) Investing Activities $3,626,000 USD -63%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 127,680,424 shares 0.97%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $25,617,000 USD -71%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $94,331,000 USD -31%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,375,000 USD 8.2%
Deferred Tax Assets, Valuation Allowance $1,267,000 USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $45,868,000 USD -8.3%
Operating Lease, Liability $59,914,000 USD -57%
Depreciation $15,273,000 USD 12%
Payments to Acquire Property, Plant, and Equipment $3,626,000 USD 63%
Lessee, Operating Lease, Liability, to be Paid $71,661,000 USD -51%
Property, Plant and Equipment, Gross $165,075,000 USD 18%
Operating Lease, Liability, Current $4,949,000 USD 16%
Operating Lease, Weighted Average Discount Rate, Percent 0.0494 pure 0.61%
Deferred Income Tax Expense (Benefit) $1,266,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11,747,000 USD 41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 870,000 shares 0%
Unrecognized Tax Benefits $1,061,000 USD 22%
Operating Lease, Payments $2,715,000 USD 10%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $3,323,000 USD -2.4%
Depreciation, Depletion and Amortization $13,995,000 USD 12%
Deferred Tax Assets, Net of Valuation Allowance $29,962,000 USD -24%
Interest Expense $2,081,000 USD 17%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%